NYSE : ABBV

AbbVie Inc. — Institutional Ownership

$250.875 USD

-$6.54 (-2.54%)

Volume
4.88M
Average Volume
6.77M
Market Capitalization
$443.24B
P/E Ratio
70.68
Dividend Yield
2.72%
Price Target
$281.00
Year High
$267.47
Year Low
$189.79
Day High
—
Day Low
—
Payout Ratio
$1.87
Current Ratio
$0.80
Institutional Ownership Summary
Institutional Ownership %

5.09%

Investors Holding

2146

change: -2038 | last: 4184
Increased Positions

1095

change: -811 | last: 1906
Reduced Positions

777

change: -946 | last: 1723
New Positions

122

change: -73 | last: 195
Sold Positions

2090

change: 1828 | last: 262
Total Calls

55300

Total Puts

31600

Put-Call Ratio

0.57

change: -57.4815 | last: 1.1462
Total Invested

44.89B

Beneficial Ownership Filings
Filing Date Reporting Person Amount Beneficially Owned % of Class
2026-04-29 Vanguard Capital Management 132.92M 7.51%
2026-03-26 The Vanguard Group - 0.00%
2025-07-07 The Vanguard Group 177.27M 10.03%
2025-02-18 AbbVie Inc. 4.35M 9.00%
2022-02-09 The Vanguard Group - 23-1945930 146.31M 8.28%
2022-02-03 (1) BlackRock, Inc. 128.2M 7.30%
2021-02-16 95-1411037 13.0 2.10%
2021-02-10 The Vanguard Group - 23-1945930 142.56M 8.08%
2021-01-29 (1) BlackRock, Inc. 124.42M 7.00%
2020-02-14 Capital Research Global Investors ** 86.6M 5.80%
2020-02-12 The Vanguard Group - 23-1945930 122.57M 8.28%
2020-02-05 (1) BlackRock, Inc. 98.59M 6.70%
2019-11-08 Capital Research Global Investors ** 94.86M 6.40%
2019-02-04 (1) BlackRock, Inc. 95.79M 6.40%
2018-02-14 Capital Research Global Investors ** 193.01M 12.00%
2018-02-08 (1) BlackRock, Inc. 101.32M 6.30%
2017-08-11 AbbVie Inc. 720.94K 4.88%
2017-05-01 AbbVie Inc. 1.19M 8.57%
2017-01-19 (1) BlackRock, Inc. 92.42M 5.70%
2016-11-10 Capital Research Global Investors ** 164.41M 10.00%
2016-06-06 AbbVie Inc. 1.64M 17.93%
2016-02-10 (1) BlackRock, Inc. 99.59M 6.10%
2015-02-09 (1) BlackRock, Inc. 114.45M 7.20%
2014-02-07 AbbVie Inc. 1.07M 5.97%
2014-01-28 (1) BlackRock, Inc. 105.53M 6.60%
ABBV Enterprise Value History
Annual
Date Stock Price Shares Outstanding Market Cap Cash & Equivalents Total Debt Enterprise Value
2025-12-31 $228.49 1.78B $406.8B $5.23B $69.07B $470.64B
2024-12-31 $177.70 1.77B $314.35B $5.52B $67.84B $376.67B
2023-12-31 $154.97 1.77B $273.99B $12.81B $60.12B $321.29B
2022-12-31 $161.61 1.77B $286.21B $9.2B $64.19B $341.2B
2021-12-31 $135.40 1.77B $239.66B $9.75B $77.58B $307.49B
2020-12-31 $107.15 1.67B $178.62B $8.45B $87.06B $257.23B
2019-12-31 $88.54 1.48B $131.13B $39.92B $67.09B $158.29B
2018-12-31 $92.19 1.54B $142.06B $7.29B $40.31B $175.09B
2017-12-31 $96.71 1.6B $154.35B $9.3B $37.37B $182.41B
2016-12-31 $62.62 1.62B $101.57B $5.1B $36.84B $133.31B
Quarterly
Date Stock Price Shares Outstanding Market Cap Cash & Equivalents Total Debt Enterprise Value
2026-06-30 $251.64 1.77B $445.65B -$ -$ $445.65B
2026-03-31 $217.49 1.77B $385.8B $9.39B $72.86B $449.26B
2025-12-31 $228.49 1.78B $406.8B $5.23B $68.87B $470.45B
2025-09-30 $231.54 1.77B $410.29B $5.63B $68.74B $473.4B
2025-06-30 $185.62 1.77B $328.92B $6.47B $70.48B $392.93B
2025-03-31 $209.52 1.77B $370.43B $5.18B $69.89B $435.15B
2024-12-31 $177.70 1.77B $314.35B $5.52B $67.84B $376.67B
2024-09-30 $197.48 1.77B $349.34B $7.26B $71.08B $413.16B
2024-06-30 $170.37 1.77B $301.38B $13.13B $70.63B $358.89B
2024-03-31 $180.76 1.77B $319.76B $18.07B $74B $375.7B
2023-12-31 $154.97 1.77B $273.67B $12.81B $60.12B $320.97B
2023-09-30 $149.06 1.77B $263.39B $13.29B $60.75B $310.85B